203 related articles for article (PubMed ID: 15006395)
1. Synthesis of novel 2-nitroimidazole-tethered tricyclic quinolines, bearing a second heteroatom, and their in vitro evaluation as hypoxia-selective cytotoxins and radiosensitizers.
Papadopoulou MV; Rosenzweig HS; Bloomer WD
Bioorg Med Chem Lett; 2004 Mar; 14(6):1523-5. PubMed ID: 15006395
[TBL] [Abstract][Full Text] [Related]
2. Nitroimidazole-based bioreductive compounds bearing a quinazoline or a naphthyridine chromophore.
Papadopoulou MV; Bloomer WD
Anticancer Drugs; 2009 Jul; 20(6):493-502. PubMed ID: 19430289
[TBL] [Abstract][Full Text] [Related]
3. Radiosensitizing and cytotoxic properties of DNA targeted phenanthridine-linked nitroheterocycles of varying electron affinities.
Cowan DS; Matejovic JF; Wardman P; McClelland RA; Rauth AM
Int J Radiat Biol; 1994 Dec; 66(6):729-38. PubMed ID: 7814971
[TBL] [Abstract][Full Text] [Related]
4. 9-[3-(2-Nitro-1-imidazolyl)propylamino]-1,2,3,4-tetrahydroacridine hydrochloride. A novel DNA-affinic hypoxic cell cytotoxin and radiosensitizer. Comparison with NLA-1.
Papadopoulou MV; Rosenzweig HS; Doddi M; Bloomer WD
Oncol Res; 1994; 6(9):439-48. PubMed ID: 7703530
[TBL] [Abstract][Full Text] [Related]
5. NLCQ-1 (NSC 709257): exploiting hypoxia with a weak DNA-intercalating bioreductive drug.
Papadopoulou MV; Bloomer WD
Clin Cancer Res; 2003 Nov; 9(15):5714-20. PubMed ID: 14654556
[TBL] [Abstract][Full Text] [Related]
6. NLNQ-1, a 2-[3-(2-nitro-1-imidazolyl) propylamino]-3-chloro-1,4-naphthoquinone, as a hypoxia-selective cytotoxin and radiosensitizer.
Papadopoulou MV; Bloomer WD
In Vivo; 2008; 22(3):285-8. PubMed ID: 18610737
[TBL] [Abstract][Full Text] [Related]
7. Radiosensitizing and toxic properties of quinoline and nitroquinoline complexes of platinum [PtCl2(NH3)quinoline].
Skov KA; Adomat H; Doedee M; Farrell N
Anticancer Drug Des; 1994 Apr; 9(2):103-17. PubMed ID: 8166927
[TBL] [Abstract][Full Text] [Related]
8. Angiogenesis inhibitor TX-1898: syntheses of the enantiomers of sterically diverse haloacetylcarbamoyl-2-nitroimidazole hypoxic cell radiosensitizers.
Jin CZ; Nagasawa H; Shimamura M; Uto Y; Inayama S; Takeuchi Y; Kirk KL; Hori H
Bioorg Med Chem; 2004 Sep; 12(18):4917-27. PubMed ID: 15336271
[TBL] [Abstract][Full Text] [Related]
9. 9-[3-(2-Nitro-1-imidazolyl)propylamino]-cyclopenteno[b]quinoline hydrochloride (NLCPQ-1): a novel DNA-affinic bioreductive agent as chemosensitizer. I.
Papadopoulou MV; Ji M; Rao MK; Bloomer WD
Oncol Res; 1997; 9(5):249-57. PubMed ID: 9306432
[TBL] [Abstract][Full Text] [Related]
10. 9-[3-(2-Nitro-1-imidazolyl)propylamino]-cyclopenteno[b]quinoline hydrochloride (NLCPQ-1). A novel DNA-affinic bioreductive agent as cytotoxin and radiosensitizer.
Papadopoulou MV; Ji M; Rao MK; Bloomer WD
Oncol Res; 1996; 8(10-11):425-34. PubMed ID: 9114435
[TBL] [Abstract][Full Text] [Related]
11. N-[2-(2-methyl-5-nitroimidazolyl)ethyl]-4-(2-nitroimidazolyl)butanamide (NSC 639862), a bisnitroimidazole with enhanced selectivity as a bioreductive drug.
Moselen JW; Hay MP; Denny WA; Wilson WR
Cancer Res; 1995 Feb; 55(3):574-80. PubMed ID: 7834627
[TBL] [Abstract][Full Text] [Related]
12. Targeting radiosensitizers to DNA by attachment of an intercalating group: nitroimidazole-linked phenanthridines.
Cowan DS; Panicucci R; McClelland RA; Rauth AM
Radiat Res; 1991 Jul; 127(1):81-9. PubMed ID: 2068275
[TBL] [Abstract][Full Text] [Related]
13. 2-Alkylsulfonyloxy-3-hydroxy-1,4-naphthoquinones: a novel class of radio- and chemosensitizers of V79 cells.
Hatzigrigoriou E; Papadopoulou MV; Shields D; Bloomer WD
Oncol Res; 1993; 5(1):29-36. PubMed ID: 8369573
[TBL] [Abstract][Full Text] [Related]
14. Hypoxia-selective antitumor agents. 8. Bis(nitroimidazolyl)alkanecarboxamides: a new class of hypoxia-selective cytotoxins and hypoxic cell radiosensitisers.
Hay MP; Wilson WR; Moselen JW; Palmer BD; Denny WA
J Med Chem; 1994 Feb; 37(3):381-91. PubMed ID: 8308864
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, transportability and hypoxiaselective binding of 1-beta-D-(5-Deoxy-5-fluororibofuranosyl)-2-nitroimidazole (beta-5-FAZR), a configurational isomer of the clinical hypoxia marker, FAZA.
Emami S; Kumar P; Yang J; Kresolic Z; Paproski R; Cass C; McEwan AJ; Wiebe LI
J Pharm Pharm Sci; 2007; 10(2):237-45. PubMed ID: 17706182
[TBL] [Abstract][Full Text] [Related]
16. 9-[3-(2-Nitro-1-imidazolyl)propylamino]-cyclopenteno[b]quinoline hydrochloride (NLCPQ-1). A novel DNA-affinic bioreductive agent as chemosensitizer: mechanistic studies. II.
Papadopoulou MV; Rosenzweig HS; Ji M; Khan SH; Bloomer WD
Oncol Res; 1998; 10(3):163-73. PubMed ID: 9700727
[TBL] [Abstract][Full Text] [Related]
17. Hypoxia-selective antitumor agents. 10. bis(nitroimidazoles) and related Bis(nitroheterocycles): development of derivatives with higher rates of metabolic activation under hypoxia and improved aqueous solubility.
Hay MP; Lee HH; Wilson WR; Roberts PB; Denny WA
J Med Chem; 1995 May; 38(11):1928-41. PubMed ID: 7783125
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of a novel nitroimidazole-spermidine derivative as a tumor-targeted hypoxia-selective cytotoxin.
Papadopoulou MV; Rosenzweig HS; Bloomer WD
Bioorg Med Chem Lett; 2004 Mar; 14(6):1519-22. PubMed ID: 15006394
[TBL] [Abstract][Full Text] [Related]
19. Novel fluorinated hypoxia-targeted compounds as Non-invasive probes for measuring tumor-hypoxia by 19F-magnetic resonance spectroscopy (19F-MRS).
Papadopoulou MV; Ji M; Bloomer WD
Anticancer Res; 2006; 26(5A):3253-8. PubMed ID: 17094437
[TBL] [Abstract][Full Text] [Related]
20. Radiosensitizers of hypoxic mammalian cells. 1-(Hydroxyaminoalkyl)-substituted nitroimidazoles.
Ahmed I; Stratford IJ; Jenkins TC
Arzneimittelforschung; 1985; 35(12):1763-8. PubMed ID: 4096727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
